LINC02799

Across TCGA pan-cancer cohorts, LINC02799 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated LINC02799 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher LINC02799 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02799 expression acts as an unfavorable survival marker, although some lineages such as LAML and LGG show a favorable association.

LIHC, ESCA, and HNSC are the cancer types where LINC02799 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	II,III,IV	0.453	0.728	.005	42	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
HNSC	OS	Tertile	IV	0.200	0.648	.007	36	view →
THCA	DFS	Tertile	IV	0.376	0.915	<.001	27	view →
LAML	DFS	Tertile	All	0.757	0.393	.022	18	view →
KIRC	DFS	Tertile	IV	0.332	0.625	.030	18	view →
DLBC	OS	Tertile	All	0.053	0.936	<.001	18	view →
READ	DFS	Tertile	IV	0.262	0.634	.016	18	view →
ACC	OS	Tertile	All	0.147	0.685	.018	18	view →
LGG	OS	Tertile	All	0.918	0.783	.009	14	view →
UCEC	DFS	Tertile	All	0.679	0.844	.037	12	view →
SKCM	DFS	Tertile	All	0.358	0.196	.026	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

LINC02799–LIHC (OS)

Open the LIHC breakdown →